Emily Meseck
Executive Director, Global Head Portfolio Pathology Novartis BioMedical Research
- Role
- Global Head, Portfolio Pathology at Novartis
- Location
- East Hanover, NJ, US
- LinkedIn followers
- 500 followers
About Emily Meseck
Experienced people leader, toxicologic (regulatory) pathologist and drug development scientist in preclinical safety. Extensive experience in AAV-gene therapies, biologics and small molecules in numerous therapeutic areas including neuroscience, oncology, ophthalmology, cardiovascular and metabolic diseases as well as ultrastructural pathology.
Experience
Global Head, Portfolio Pathology
Jun 2023 — Present · East Hanover, NJ, US
Education
State University of New York at Plattsburgh
B.S., Cellular Biochemistry
1994 — 1997
Cornell University
Residency, Anatomic Pathology
2002 — 2005
Cornell University College of Veterinary Medicine
Doctor's Degree, Veterinary Medicine
Cornell University
DVM, Veterinary Medicine
1998 — 2002
Geisel School of Medicine at Dartmouth
Master of Public Health - MPH, Diversity and Inclusion in Clinical Trials
Skills
- Biomarkers
- In Vivo
- Drug Development
- Veterinary
- Life Sciences
- Clinical Development
- Animal Models
- Pathology
- Drug Safety
- Drug Discovery
- Good Laboratory Practice (Glp)
- Glp
- Toxicology
- Immunohistochemistry
- Ind
- Veterinary Medicine
- Pharmacology
- Translational Medicine
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.